Liver sympathetic denervation reverses obesity‐induced hepatic steatosis
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Key points: Non‐alcoholic fatty liver disease, characterized in part by elevated liver triglycerides (i.e. hepatic steatosis), is a growing health problem. In this study, we found that hepatic steatosis is associated with robust hepatic sympathetic overactivity. Removal of hepatic sympathetic nerves reduced obesity‐induced hepatic steatosis. Liver sympathetic innervation modulated hepatic lipid acquisition pathways during obesity. Non‐alcoholic fatty liver disease (NAFLD) affects 1 in 3 Americans and is a significant risk factor for type II diabetes mellitus, insulin resistance and hepatic carcinoma. Characterized in part by excessive hepatic triglyceride accumulation (i.e. hepatic steatosis), the incidence of NAFLD is increasing – in line with the growing obesity epidemic. The role of the autonomic nervous system in NAFLD remains unclear. Here, we show that chronic hepatic sympathetic overactivity mediates hepatic steatosis. Direct multiunit recordings of hepatic sympathetic nerve activity were obtained in high fat diet and normal chow fed male C57BL/6J mice. To reduce hepatic sympathetic nerve activity we utilized two approaches including pharmacological ablation of the sympathetic nerves and phenol‐based hepatic sympathetic nerve denervation. Diet‐induced NAFLD was associated with a nearly doubled firing rate of the hepatic sympathetic nerves, which was largely due to an increase in efferent nerve traffic. Furthermore, established high fat diet‐induced hepatic steatosis was effectively reduced with pharmacological or phenol‐based removal of the hepatic sympathetic nerves, independent of changes in body weight, caloric intake or adiposity. Ablation of liver sympathetic nerves was also associated with improvements in liver triglyceride accumulation pathways including free fatty acid uptake and de novo lipogenesis. These findings highlight an unrecognized pathogenic link between liver sympathetic outflow and hepatic steatosis and suggest that manipulation of the liver sympathetic nerves may represent a novel therapeutic strategy for NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 6×
“Previous findings indicate that 60% of hepatic triglycerides are derived from plasma non-esterified FFAs (Donnelly et al. 2005), which are taken up by hepatocyte cell membrane transporters, including cluster of differentiation 36 (CD36) (Coburn et al. 2000) and fatty acid transport proteins (FATPs) (Doege et al. 2006).”
BackgroundInfluentialLambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069 · cited 1×
“Liver triglycerides are also synthesized from glucose via de novo lipogenesis, with this pathway contributing to 25% of the total hepatic triglyceride pool in NAFLD individuals (Donnelly et al. 2005; Lambert et al. 2014).”
BackgroundCoburn, C. T., Knapp, F. F., Febbraio, M., Beets, A. L., Silverstein, R. L., & Abumrad, N. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003826200 · Cited by 726
The Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616
Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver
Monetti, M., Levin, M. C., Watt, M. J., Sajan, M. P., Marmor, S., Hubbard, B. K., Stevens, R. D., Bain, J. R., Newgard, C. B., Farese, R. V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.005 · Cited by 511 · cited 1×
“In this context, liver specific overexpression of DGAT results in hepatic steatosis, independent of insulin resistance (Monetti et al. 2007).”
BackgroundSchwarz, J.-M., Linfoot, P., Dare, D., & Aghajanian, K. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.1.43 · Cited by 496
Loewy, A. D. (1990) · Central Regulation of Autonomic Functions · doi:10.1093/oso/9780195051063.003.0006 · Cited by 396
Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB
Purkayastha, S., Zhang, G., & Cai, D. (2011) · Nature Medicine · doi:10.1038/nm.2372 · Cited by 220 · cited 2×
“Moreover, sympathetic overactivity has been suggested to lead to insulin resistance (Purkayastha et al. 2011b).”
BackgroundThe Integrative Role of CNS Fuel-Sensing Mechanisms in Energy Balance and Glucose Regulation
Sandoval, D., Cota, D., & Seeley, R. J. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.120806.095256 · Cited by 178 · cited 1×
“While essential, it is important to consider that the central nervous system (CNS) is intimately involved in metabolic regulation, with alterations in CNS networks emerging as key culprits in metabolic disease processes (Sandoval et al. 2008; Purkayastha & Cai, 2013).”
BackgroundMitsuyoshi, H., Yasui, K., Harano, Y., Endo, M., Tsuji, K., Minami, M., Itoh, Y., Okanoue, T., & Yoshikawa, T. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00464.x · Cited by 172 · cited 1×
“6A), which is consistent with previous findings in humans and rodents (Koonen et al. 2007; Mitsuyoshi et al. 2009; Miquilena-Colina et al. 2011) and suggestive of increased hepatic FFA uptake during NAFLD.”
ResultYoung, C. N., Morgan, D. A., Butler, S. D., Mark, A. L., & Davisson, R. L. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00405 · Cited by 58
Self-citation
Cited by
Metabolic stress drives sympathetic neuropathy within the liver
Liu, K., Yang, L., Wang, G., Liu, J., Zhao, X., Wang, Y., Li, J., & Yang, J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.012 · Cited by 146
Adori, C., Daraio, T., Kuiper, R., Barde, S., Horvathova, L., Yoshitake, T., Ihnatko, R., Valladolid-Acebes, I., Vercruysse, P., Wellendorf, A. M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg5733 · Cited by 105
“A recent study depicted a more direct patho genic link between liver sympathetic outflow and hepatic steatosis ( 14 ).”
BackgroundHepatic Nervous System in Development, Regeneration, and Disease
Miller, B. M., Oderberg, I. M., & Goessling, W. (2021) · Hepatology · doi:10.1002/hep.32055 · Cited by 89
FGF21 reverses MASH through coordinated actions on the CNS and liver
Rose, J. P., Morgan, D. A., Sullivan, A. I., Fu, X., Inigo-Vollmer, M., Burgess, S. C., Meyerholz, D. K., Rahmouni, K., & Potthoff, M. J. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.04.014 · Cited by 75
Self-citationA brain-to-liver signal mediates the inhibition of liver regeneration under chronic stress in mice
Zhou, Y., Lin, X., Jiao, Y., Yang, D., Li, Z., Zhu, L., Li, Y., Yin, S., Li, Q., Xu, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54827-5 · Cited by 31
Metadata
- Authors
- Hurr, C., Simonyan, H., Morgan, D. A., Rahmouni, K., & Young, C. N.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2019-07-26
- Volume
- 597
- Issue
- 17
- Pages
- 4565-4580
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W2954541606
- Cited by
- 128
- References
- 13
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.